RecruitingNCT06568679
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Striving for Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer (EOCRC); BIO-EOCRC Study
Sponsor
The Netherlands Cancer Institute
Enrollment
300 participants
Start Date
Jan 27, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to collect high quality clinical data on lifestyle and patient biomaterials prior to start or during / after treatment of early-onset colorectal cancer (EOCRC) and to inform on treatment and survival outcomes of EOCRC patients.
Eligibility
Min Age: 18 YearsMax Age: 49 Years
Inclusion Criteria5
- Patients with locoregional or metastatic colorectal cancer (CRC)
- Histologically proven CRC
- Age 18 - 49 years at time of first CRC diagnosis
- Able to understand the informed consent form
- Provide written informed consent.
Exclusion Criteria2
- Mentally incompetent patients based on the opinion of treating physician
- Inability to understand the Dutch language
Interventions
OTHERNo intervention; observational
No intervention; observational
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06568679